1st Quarter - Report

KNIGHT CAPITOL CONSULTANTS for INDIVIOR, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Adequacy of funding for state-based efforts to provide treatment for substance use disorders

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Funding for mental health and substance abuse research and grants; issues related to provisions affecting regulation and pricing of pharmaceuticals in the Build Back Better Act (H.R. 5376).

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th)

Medicare/Medicaid MMM

The Medicaid Re-entry Act (H.R. 955/S. 445); policies related to reimbursement of substance use disorder treatment (no specific legislation). Possible changes in reimbursement for pharmaceuticals (HR 3, HR 5376 - Build Back Better Act, and any successor legislation)

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch (1999-2007)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 445 (117th), H.R. 5376 (117th), H.R. 3 (117th), H.R. 955 (117th)

Health Issues HCR

Implementation of section 3204 of the SUPPORT Act, PL 115-271; Mainstreaming Addiction Treatment Act (HR 2067); Medication Access and Training Expansion Act; (S 5000). Drug Enforcement Administration regulation of buprenorphine under the Controlled Substances Act.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2067 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.